Event Capital Strategies

Event Capital Strategies seeks to invest broadly in healthcare. We were founded on the premise that a significant opportunity exists to disrupt the healthcare sector through new technologies and business model innovation. Our investment strategy is thematic and backed by our unique perspective, bold ideas, global network, and decades of experience acquiring and operating companies. We target large addressable and consolidated markets that can be disrupted through innovation. WE ARE FOCUSED ON BUT NOT LIMITED TO ▪ Medication Management ▪ Orthopedics ▪ Life Sciences ▪ Diagnostics ▪ Healthcare IT & Service EXPERTISE & APPROACH Event Capital Strategies supports our platform investments through a robust team of operating partners who have come from leading healthcare and pharmaceutical companies or are medical doctors. We provide hands-on strategic and functional support to our portfolio companies and stand by to work alongside management as partners or temporarily fill management gaps when needed. Our operating team also enables Event to stand up businesses and carveouts more efficiently and rapidly and drive synergy across our portfolio. Returns in our portfolio are derived directly from the execution of our investment strategy and from fundamental improvements—operational, managerial, financial—that we enable during our ownership period. Our investments may be standalone businesses or may involve the simultaneous acquisition of multiple companies to create the foundation to achieve our investment goals. The unifying theme of our investments is a cohesive strategy, developed at the outset, that forms the basis of an execution plan that is rigorously pursued to improve the underlying business operations, accelerate growth, create and/or enhance competitive differentiation, and substantially boost profitability.